The link between CYP2C19 and weight loss is not well established. CYP2C19 is a drug-metabolizing enzyme affecting medications like clopidogrel, proton pump inhibitors, and some antidepressants. While some of these drugs can influence body weight (e.g., mirtazapine may increase appetite), the genetic variant itself has no proven direct effect on weight loss. Consumer DNA tests often overstate weak associations. For weight management, focus on calorie balance, exercise, and a healthy diet rather than CYP2C19. If you take weight-relevant medications, a doctor can consider your CYP2C19 status for dosing. Evidence: mostly mechanistic, lacking robust clinical trials for weight loss. Sources: none in the provided context.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-41eaf3c691b5ca4f08a24082